On the other hand, more recently, several works performed on ER + BC reported that FOXA1 expression was significantly associated with a favorable prognosis [4,47,66,67] also in tamoxifen-treated BC patients [68] and was a predictor of late recurrences [47]. The gene discussed is FOXA1; the disease is breast cancer.